Promoter hypermethylation of tumor-related genes in peritoneal lavage and the prognosis of patients with colorectal cancer

Journal of Surgical Oncology

Volumn 100, Issue 1, 2009, Pages 69-74

  Kamiyama, Hidenori ^a   Noda, Hiroshi ^a   Takata, Osamu ^a   Suzuki, Koichi ^a   Kawamura, Yutaka ^a   Konishi, Fumio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Methylation; Peritoneal lavage; Quantitative methylation specific PCR

Indexed keywords

APC PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERITONEUM LAVAGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN METHYLATION; COLORECTAL TUMOR; GENETICS; LAVAGE; METABOLISM; MIDDLE AGED; MORTALITY; PERITONEUM; PROMOTER REGION;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA METHYLATION; FEMALE; HUMANS; IRRIGATION; MALE; MIDDLE AGED; PERITONEUM; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS, GENETIC;

EID: 67649388221     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21291     Document Type: Article

References (35)

1. Leather AJM, Kocjan G, Savage F, et al.: Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancer. Dis Colon Rectum 1994;37:814-819. (Pubitemid 24255130)
2. Wind P, Nordlinger B, Roger V, et al.: Long-term prognostic value of positive peritoneal washing in colon cancer. Scand J Gastroenterol 1999;34:606-610. (Pubitemid 29339215)
3. Belinsky SA: Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 2004;4:707-717. (Pubitemid 39215069)
4. Topaloglu O, Hoque MO, Tokumaru Y, et al.: Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. Clin Cancer Res 2004;10:2284-2288. (Pubitemid 38445685)
5. Hoque MO, Begum S, Topaloglu O, et al.: Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res 2004;64:5511-5517. (Pubitemid 39006576)
6. Carvalho AL, Jeronimo C, Kim MM, et al.: Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res 2008;14:97-107.
7. Fackler MJ, Malone K, Zhang Z, et al.: Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res 2006;12:3306-3310. (Pubitemid 43910873)
8. Usadel H, Brabender J, Danenberg KD, et al.: Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 2002;62:371-375. (Pubitemid 34106406)
9. Koike H, Ichikawa D, Ikoma H, et al.: Comparison of methylation-specific polymerase chain reaction (MSP) with reverse transcriptase-polymerase chain reaction (RT-PCR) in peripheral blood of gastric cancer patients. J Surg Oncol 2004;87: 182-186. (Pubitemid 39167385)
10. Laird PW: The power and the promise of DNA methylation markers. Nat Rev Cancer 2003;3:253-266. (Pubitemid 37328861)
11. Sidransky D: Emerging molecular markers of cancer. Nat Rev Cancer 2002;2:210-219. (Pubitemid 37328790)
12. Miyamoto K, Ushijima T: Diagnostic and therapeutic applications of epigenetics. Jpn J Clin Oncol 2005;35:293-301. (Pubitemid 41444276)
13. Muller HM, Oberwalder M, Fiegl H, et al.: Methylation changes in faecal DNA: A marker for colorectal cancer screening? Lancet 2004;363:1283-1285.
14. Zou HZ, Yu BM, Wang ZW, et al.: Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin Cancer Res 2002;8:188-191. (Pubitemid 34101476)
15. Jubb AM, Quirke P, Oates AJ: DNA methylation, a biomarker for colorectal cancer. Ann NY Acad Sci 2003;983:251-267.
16. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-428. (Pubitemid 34587077)
17. Herman JG, Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042-2054. (Pubitemid 37448928)
18. Noda H, Miyaji Y, Nakanishi A, et al.: Frequent reduced expression of alpha-1B-adrenergic receptor caused by aberrant promoter methylation in gastric cancers. Br J Cancer 2007;96:383-390. (Pubitemid 46160646)
19. Esteller M, Corn PG, Baylin SB, et al.: A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-3229. (Pubitemid 32695003)
20. Lind GE, Thorstensen L, Lovig T, et al.: A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer 2004;3:28. (Pubitemid 40230544)
21. Lee S, Hwang KS, Lee HJ, et al.: Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. Lab Invest 2004;84:884-893. (Pubitemid 38833248)
22. Noda H, Mashima R, Kamiyama H, et al.: Promoter hypermethylation of tumor-related genes in sporadic colorectal cancer in young patients. J Exp Clin Cancer Res 2007;26:521-526. (Pubitemid 351157870)
23. Herman JG, Graff JR, Myohanen S, et al.: Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:821-826. (Pubitemid 26296693)
24. Eads CA, Danenberg KD, Kawakami K, et al.: MethyLight: A high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000;28:E32.
25. Harden SV, Tokumaru Y, Westra WH, et al.: Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Clin Cancer Res 2003;9:1370-1375. (Pubitemid 36418388)
26. Cottrell SE: Molecular diagnostic applications of DNA methylation technology. Clin Biochem 2004;37:595-604. (Pubitemid 38845022)
27. Kienle P, Koch M: Are micrometastases of the peritoneum equivalent to distant metastases? Dig Surg 2002;19:453-458.
28. Ushijima T: Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 2005;5:223-231. (Pubitemid 40314953)
29. Muller HM, Widschwendter A, Fiegl H, et al.: DNA methylation in serum of breast cancer patients: An independent prognostic marker. Cancer Res 2003;63:7641-7645. (Pubitemid 37466689)
30. Lofton-Day C, Lesche R: DNA methylation markers in patients with gastrointestinal cancers. Dig Dis 2003;21:299-308.
31. Leung WK, To KF, Chu ESH, et al.: Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer. Br J Cancer 2005;92:2190-2194. (Pubitemid 40966256)
32. Kawakami K, Brabender J, Lord RV, et al.: Hypermethylation APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst 2000;92:1805-1811. (Pubitemid 30945195)
33. Nguyen DX, Massague J: Genetic determinants of cancer metastasis. Nat Rev Genet 2007;8:341-352. (Pubitemid 46625811)
34. Vecchi M, Confalonieri S, Nuciforo P, et al.: Breast cancer metastases are molecularly distinct from their primary tumors. Oncogene 2008;27:2148-2158.
35. Schmiemann V, Bocking A, Kazimirek M, et al.: Methylation assay for the diagnosis of lung cancer on bronchial aspirates: A cohort study. Clin Cancer Res 2005;11:7728-7734. (Pubitemid 41611615)